WThe Canadian Biosafety Standard, third edition (CBS3) webinar series part two was held February 8th, 2023. This webinar included a short presentation on CBS3 as well as a dedicated question and answer period. The intent of this session is to guide facilities in implementing and achieving compliance with CBS3 requirements.
The Public Health Agency of Canada will be hosting a two-part webinar series dedicated to the CBS3. The first webinar will provide an overview of key changes in the CBS3 from the previous edition, project milestones, and highlights from the public consultation.
On November 28, 2022, the World Health Organization began using ‘mpox’ as the preferred term for monkeypox disease.
Target Audience: External stakeholders planning to, or currently working with, MPXV
Target Audience: licence holders, biological safety officers, and other personnel who are responsible for developing and implementing biosecurity plans
Did you know that all research with pathogens and toxins has some level of dual-use potential? This interactive webinar will provide participants with an overview of the concept of dual-use in life sciences research. Dual-use examples will be presented as they relate to research products, knowledge, and technology. Participants will also be provided with methods to identify, assess and mitigate dual-use risks.
Target Audience: Licence Holders, Biological Safety Officers, and researchers who study pathogens and toxins